ANN ARBOR, Mich. - For status epilepticus patients who experience seizures outside of the hospital, treatment administered on an ambulance is an important component of their overall care. And, ...

Patients treated with 5-mg midazolam nasal spray were more likely than those given placebo to remain seizure free for 6 hours after treatment or have their seizure terminated within 10 minutes, with ...

01AFTC2Z – Illustration of a brain showing epileptic seizure activity, front view. Electroencephalogram (EEG) tracings show abnormal waveforms emanating from the temporal lobe (blue-green) ofthe brain ...

Status epilepticus is a medical emergency associated with significant morbidity and mortality. It is defined as "a single epileptic seizure of >30-min duration or a series of epileptic seizures during ...

The product was approved in May based on data from the phase 3, placebo-controlled ARTEMIS 1 trial that evaluated the safety and efficacy of the intranasal benzodiazepine in 292 patients. Nayzilam ...

Please provide your email address to receive an email when new articles are posted on . Rafa Laboratories announced the FDA has granted approval for its 10 mg midazolam autoinjector to treat status ...

Nayzilam (midazolam) is a prescription drug that’s used to treat certain types of seizures. The drug comes as nasal spray. It’s used as an immediate treatment of seizure clusters. Nayzilam is used in ...

The use of nasal sprays for the treatment of epilepsy has gained considerable attention lately. At this past May's American Academy of Neurology (AAN) meeting, Washington University epileptologist R.